Digital Marketing Software Market To Make Great Impact In Near Future by 2027

The global digital marketing software market size is expected to reach USD 151.8 billion by 2027, registering a of CAGR 17.4% from 2020 to 2027, according to a new study conducted by Grand View Research, Inc. The software can integrate multiple digital content delivery platforms so that organizations can plan, design, and execute marketing campaigns on their own. The software is utilized by companies to perform an in-depth and real-time analysis of campaigns. The proliferation of the internet and the growing use of social media are encouraging companies to increase their spending on creating interactive and intuitive digital content for marketing purposes. This, in turn, is anticipated to drive the market over the forecast period.

The advent of social media has dramatically enabled organizations to increase customer engagement via influencers, allowing organizations to engage in content-driven publicity. Furthermore, the on-going innovations in digital marketing technologies such as virtual influencers and its subsequent applications in the retail industry are anticipated to fuel market growth. For instance, Channel S.A and PRADA have adopted Lil Miquela, a virtual influencer developed by Brud for advertising their products. Moreover, the increasing adoption of Voice of the Customer (VoC) techniques such as online-hosted customer communities that defines a customer’s preference for future products is anticipated to boost the demand for the software over the forecast period. Moreover, the outbreak of COVID-19 has positively impacted the market owing to the increasing social media marketing activities among industries such as automotive, BFSI, education, and healthcare.

Artificial Intelligence (AI) is extensively used to build data models automatically in digital forms and collect data from multiple sources. AI is positively impacting the market, as organizations are emphasizing the adoption of this technology for improving the customer experience. For instance, CogniCor Technologies has integrated AI in its digital marketing software to enable end users to enhance the complaint resolution activities, resulting in an increased level of customer satisfaction. Thereby, the companies offering AI in their software are likely to stay competitive in the market.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/digital-marketing-software-dms-market

Further key findings from the report suggest:

• The marketing automation software is anticipated to gain traction over the forecast period to perform activities such as lead nurturing and collaboration among teams to promote business
• The managed services segment is expected to grow significantly over the forecast period. This can be attributed to the advantages provided by managed services such as remote monitoring and cost-effective management of IT infrastructure through subscription-based pricing models
• The cloud deployment model is expected to gain traction over the forecast period due to its cost-effectiveness and increased accessibility
• The SMEs segment is anticipated to grow remarkably owing to the increasing adoption of social media platforms such as Facebook, Pinterest, and Instagram, by SMEs for activities related to sales and promotion
• In Asia Pacific, the digital marketing software market is anticipated to witness significant growth owing to increasing popularity of social media, e-commerce, and m-commerce particularly in emerging economies such as India, Indonesia, and Thailand
• Key players operating in the market include Adobe, Inc.; Hewlett Packard Enterprise Company; Hubspot, Inc.; IBM Corporation; Marketo, Inc.; Microsoft Corporation; Oracle Corporation; Salesforce.com, Inc.; SAP SE; and SAS Institute, Inc.

Grand View Research has segmented the global digital marketing software market based on solution, service, deployment, enterprise size, end use, and region.

Digital Marketing Software Solution Outlook (Revenue, USD Million, 2016 - 2027)

• CRM Software
• Email Marketing
• Social Media
• Search Marketing
• Content Management
• Marketing Automation
• Campaign Management
• Others

Digital Marketing Software Service Outlook (Revenue, USD Million, 2016 - 2027)

• Professional Services
• Managed Services

Digital Marketing Software Deployment Outlook (Revenue, USD Million, 2016 - 2027)

• Cloud
• On-premise

Digital Marketing Software Enterprise Size Outlook (Revenue, USD Million, 2016 - 2027)

• Large Enterprises
• Small & Medium Enterprises (SMEs)

Digital Marketing Software End-use Outlook (Revenue, USD Million, 2016 - 2027)

• Automotive
• BFSI
• Education
• Government
• Healthcare
• Manufacturing
• Media & Entertainment
• Others

Digital Marketing Software Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
• Asia Pacific
  • China
  • India
  • Japan
• Latin America
  • Brazil
• MEA

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contactless Payments Market Expectations Acme Prominent Development in Developed Regions, Details GVR Study

The global contactless payments market is expected to reach USD 2.23 trillion (transaction value) by 2025, according to a new report by Grand View Research, Inc. The contactless payments industry is expected to witness lucrative growth over the forecast period owing to innovations in technologies such as IoT, which acts as a major market driver.

Benefits such as reduction in transaction time and improved service delivery offered by contactless payments have resulted in a significant rise in the number of users. Some of the key features of contactless systems include easy installation and cost effectiveness. The rising trend of making payments through QR codes and mobile phones is expected to drive the market demand. Individuals largely prefer using contactless payment as it eliminates the need to carry cash.

North America is expected to emerge as one of the key regional markets over the forecast period. The growth is mainly attributed to the increasing deployment of cloud-based contactless payment technologies in various verticals such as transportation. Europe is expected to be another major region for contactless payments owing to the growing number of smart card rollouts. Countries in the Asia Pacific region, such as Australia, Taiwan, and Japan, have witnessed a higher penetration rate of contactless payments compared to other countries.

The contactless payments market can be segmented on the basis of devices into smartphones and wearables, point of sale terminals, and smart cards. The market can also be segmented on the basis of solutions into payment terminal solution, transaction management, security and fraud management, hosted point of sale, and analytics.

To Request A Sample Copy Or View Summary Of This Report

Further key findings from the report suggest:

• Contactless payments are widely used in several sectors such as retail, transportation, healthcare, and hospitality. Smartphones and wearables emerged as the largest device segment in 2016. It is estimated to register a CAGR of 34.0% over the forecast period.
• The transportation segment is estimated to grow at a CAGR of 37.1% over the forecast period.
• The Asia Pacific market is projected to witness substantial growth over the next decade owing to various technological developments across major economies. The regional market is expected to grow at a CAGR of 35.5 % from 2017 to 2025.
• The payment terminal solution segment is expected to witness the largest growth over the forecast period as these solutions can connect the customers directly to service providers of contactless payments.
• Key participants in the contactless payments industry include Gemalto, Visa Inc., Giesecke & Devrient GmbH, Heartland Payment Systems, Verifone, Ingenico Group SA, On Track Innovations Ltd., Oberthur Technologies (OT) Morpho, Thales Group, and Wirecard AG. In March 2017, Wirecard AG acquired MyGate Communication, a payment service provider in Africa.

Grand View Research has segmented the contactless payments market based on devices, solutions, application, and regions:

Device Outlook (Revenue, USD Billion; 2014 - 2025)

• Smartphones and wearables
• Point-of-sale terminals
• Smart cards

Solution Outlook (Revenue, USD Billion; 2014 - 2025)

• Payment terminal solution
• Transaction management
• Security and fraud management
• Hosted point-of-sale
• Analytics

Application Outlook (Revenue, USD Billion; 2014 - 2025)

• Retail
• Transportation
• Healthcare
• Hospitality
• Government

Regional Outlook (Revenue, USD Billion; 2014 - 2025)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
• Asia Pacific
  • China
  • Japan
  • Australia
• South America
  • Brazil
• MEA

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Pay TV Market Projected To Be Worth USD 260.0 Billion By 2027

The global pay TV market size is anticipated to reach USD 260.0 billion by 2027, exhibiting a CAGR of 1.7% over the forecast period, according to a new report by Grand View Research, Inc. Rising competition from OTT media providers is prompting pay TV operators to disrupt existing business models and strategize more efficient profit generation methodologies. Additionally, emerging players, such as MOBITV, offer customized, cost-effective, and flexible options to their customers according to their demand, thus ensure customer satisfaction. This is expected to prompt new and existing players to diversify their existing service offerings and ensure healthy competition in the market for pay TV. 

The IPTV segment is expected to witness significant growth over the forecast period due to the advent of 5G technology. Increased bandwidth and enhanced ability to build virtual end-to-end networks for specific applications is a major driving factor for the industry. Additionally, the rapid proliferation of the 5G delivery model in emerging economies is expected to provide consumers with a high-definition 4K viewing experience. Moreover, the adoption of 5G integrated with IPTV services is expected to enable the hospitality industry to improve its service offerings. The technology is expected to facilitate more efficient data collection, analysis, and optimization to offer more personalized television viewing experience to the hospitality industry.

Furthermore, Multi-access Edge Computing (MEC) technology is expected to bring content and applications closer to the network edge, thus reducing latency and enable service optimization. MEC facilitates users to access content with minimum delay and increase IPTV network capacity via Software-Defined Networks (SDN), which improves the user’s quality of experience, thus offering encouraging growth prospects to the market. Additionally, MEC is also expected to offer enhanced security to the network system by safeguarding viewers’ information and television viewing trends, which is expected to drive the market for pay TV over the forecast period.

Rising demand amongst customers to access television from anywhere in the world on various devices such as mobile phones and tabs is promoting service providers to adopt cloud computing methodologies. Cloud computing offers a flexible and unified platform to holistically manage content monetization and security, thus enabling service providers to simplify business practices. Furthermore, the adoption of cloud technology also enables service providers to leverage the ‘as-a-service’ business model, thereby helping to generate new and sustained revenue streams.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/pay-television-tv-market

Further key findings from the report suggest:

• The IP segment is expected to witness a CAGR of more than 7.0%, owing to rising adoption of OTT media platforms amongst customers
• The satellite TV segment will continue to witness significant growth over the forecast period. The growth can be associated with the provision of offering customers with low-priced access to live coverage of important events
• Asia Pacific is expected to emerge as the fastest-growing regional market due to comparatively lower internet rates and daily content upgrades, thus ensuring easier access to consumers
• Some of the key players in the pay TV market are DIRECTV, DISH Network Corporation, Carter Communications, Foxtel, and Comcast Corporation.

Grand View Research has segmented the global pay TV market on the basis of technology, and region:

Pay TV Technology Outlook (Subscribers, Million; Revenue, USD Billion, 2016 - 2027)

• Cable TV
• Satellite TV
• Internet Protocol Television (IPTV)

Pay TV Regional Outlook (Subscribers, Million; Revenue, USD Billion, 2016 - 2027)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • China
  • India
  • Japan
• Latin America
  • Brazil
  • Mexico
• MEA

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

B2C e-commerce Market Latest Innovations, Drivers and Industry Key Events By 2025

The global B2C e-commerce market size is anticipated to reach USD 7,724.8 billion by 2025, growing at a CAGR of 11.7%, according to a new report by Grand View Research, Inc. The rising disposable income level, increasing middle-class population and increasing internet & smartphones penetration is likely to spur the market demand over the forecast period. The increasing acceptance of technology is allowing the e-commerce sector to be more efficient and reachable. The growing middle-class population and intense use of social media is also aggravating the demand of online purchasing of various products and services.

MEA region have a dynamic young population with one of the highest global per capita income. In addition to it, high level internet penetration is rapidly evolving online shopping market in the region. Chinese market is going through a consumer revolution, international products taking benefit of innovative marketing, research techniques and advertising. Brand consciousness is getting more importance in attracting Chinese consumers. Luxury goods and service providers are experiencing great growth in China.

The General Agreement on Trade in Services (GATS) provides the rules and regulations governing international trade in services, with great implications for e-commerce. Anti-Spam Law is placed to protect consumers from receiving unsolicited marketing material. As online business collects information of consumers, it cannot legally spam people without having them consent to it. Technological advancement is driving the global market. Retailers and e-commerce players are using augmented reality (AR) technology to enhance the shopping experience. This allow customers to try a product virtually.

The market is very volatile in nature and is experiencing a fierce competition, therefore, marked by an extensive presence of mergers and acquisitions. The key players in the market include Amazon, Alibaba, Jindong, Flipkart, and PayPal. E-commerce market players are focusing on unique changes to their business models in order to enable sellers & consumers to transact online. The big retailers in the market are trying to complement their traditional retailing with online commerce and tying up with other big e-commerce players.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/b2c-e-commerce-market

Further key findings from the report suggest:

• The escalating middle-class population and technological advancements are expected to drive the market.
• The travel & tourism segment is expected to portray high growth rate with a CAGR of 15.8% over the projected period
• Increasing internet penetration and growing acceptance of smartphones are expected to be the drivers of the market over the forecast period.
• The Asia Pacific region dominated the B2C e-commerce market in terms of revenue in 2016 and is expected to have significant growth over the forecast period.
• The key players of the market include Alibaba (China), Amazon.com, Inc.(U.S.), and eBay Inc. (U.S.)

Grand View Research has segmented the global B2C e-commerce market based on type, application and regions:

B2C e-commerce Type Outlook (Revenue, USD Billion; 2014 - 2025)

• B2C Retailers
• Classifieds

B2C e-commerce Application Outlook (Revenue, USD Billion; 2014 - 2025)

• Automotive
• Beauty & Personal Care
• Books & Stationery
• Consumer Electronics
• Clothing & Footwear
• Home Décor
• Industrial & Science
• Sports & Leisure
• Travel & Tourism

B2C e-commerce Regional Outlook (Revenue, USD Billion; 2014 - 2025)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
• South America 
  • Brazil 
• Middle East and Africa (MEA)

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

U.S. Sterilization Services Market Top Players, Segments, Cost Structure, Demand, Sales by 2025

The U.S. sterilization services market size is expected to reach USD 2.72 billion by 2025, according to a new report by Grand View Research, Inc., registering a 5.1% CAGR during the forecast period. Supportive government investments in the healthcare industry, increasing R&D activities, and rising volume of drug launches are key factors impacting market growth.

The U.S. government has been keen on curbing healthcare costs and this is anticipated to encourage the FDA to speed up approval procedures for generic pharmaceuticals. Faster approvals drive the need for newer sterility testing methods, compelling innovative market participants to spend more on such solutions, thereby propelling the market. With increasing demand for drugs, companies are launching newer drugs with different routes of administration, dosage, or for a new indication. These launches require thorough sterility testing and this is anticipated to drive market growth.

By end use, the market is divided into hospitals, pharmaceuticals, medical device companies, clinical laboratories/research centers, and others, which includes food and beverage companies. Hospitals dominated the overall sterilization services market in 2016 and the segment is expected to retain its top position throughout the forecast period. Increasing incidence of hospital-acquired infections, growing number of surgical procedures, and constantly rising patient pool are prime factors driving this segment.

Currently, the U.S. sterilization services industry is consolidated in nature with only a few top companies capturing the major share. Some of the leading players are STERIS Corporation; Getinge Group; and Advanced Sterilization Products Services, Inc. Other prominent companies include 3M, Belimed, Cantel Medical, MATACHANA GROUP, and Sterigenics International LLC. In September 2016, Cantel announced the acquisition of Vantage Endoscopy’s endoscopy assets. This expansion of direct sales and acquisition of assets of its Canadian distributor is expected to strengthen the company’s position in the infection prevention market.

To request a sample copy or view summary of this report, click the link below:https://www.grandviewresearch.com/industry-analysis/us-sterilization-services-market

Further key findings from the report suggest:

• The U.S. sterilization services market was valued at USD 1.83 billion in 2017 and is expected to grow lucratively over the forecast period
• In terms of revenue, the offsite delivery mode segment is anticipated to exhibit a strong growth rate through 2025
• The contract services market was valued at USD 1.27 billion in 2017 and is anticipated to register the fastest CAGR over the forecast period.                    

Grand View Research has segmented the U.S. sterilization services market on the basis of technique, type, delivery mode, and end use:

U.S. Sterilization Services Technique Outlook (Revenue, USD Million, 2012 - 2025)

• Steam
• EtO
• E-beam radiation
• Gamma radiation
• Others

U.S. Sterilization Services Type Outlook (Revenue, USD Million, 2012 - 2025)

• Contract services
• Validation services

U.S. Sterilization Services Delivery Mode Outlook (Revenue, USD Million, 2012 - 2025)

• Onsite
• Offsite

U.S. Sterilization Services End-use Outlook (Revenue, USD Million, 2012 - 2025)

• Hospitals
• Pharmaceutical companies
• Medical device companies
• Clinical laboratories
• Others

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

X-ray Systems Market to Reach Around USD 10.43 Billion by 2025

The global x-ray systems market size is expected to reach USD 10.43 billion by 2025, according to a new report by Grand View Research, Inc., registering a 2.9% CAGR during the forecast period. Rising investments in medical technology, increasing R&D activities, and surge in product launches are key factors driving market growth.

Prominent modalities include radiography, fluoroscopy, and computed radiography. Computed radiography systems are the most preferred systems, as they provide sharp images in a shorter time. Moreover, the imaging plates can be reused. Fluoroscopy is also gaining prominence in developed countries such as U.S. and Canada.

X-ray systems can be stationary or portable. Even the stationary systems dominated the market in 2017 in terms of revenue, the portable kind are poised to witness faster growth. Stationary radiography systems have significant demand in developing countries where adaption to new technology is slow. Portable systems are preferred over stationary variants due to their mobility, which makes them more convenient and flexible for use.

Some of the key players in this market are Koninklijke Philips N.V.; GE Healthcare; Hitachi, Ltd.; Shimadzu Corporation, Fujifilm Medical Systems; Siemens Healthineers; Canon Medical Systems Corporation; Carestream Health; Hologic, Inc.; and Biosign. Expansion of regional and service portfolio and merger and acquisitions are some of the leading strategic undertakings adopted by these players. For instance, in December 2016, Hitachi acquired Kurt & Kurt, a medical diagnostic system provider, to expand its businesses in Turkey.

To request a sample copy or view summary of this report, click the link below:https://www.grandviewresearch.com/industry-analysis/x-ray-systems-market

Further key findings from the report suggest:

• The global X-ray systems market was valued at USD 8.3 billion in 2017 and is expected to at a modest pace over the forecast period
• Based on type, digital systems are anticipated to grow at the fastest rate as analog systems fade out
• By modality, the computed radiography segment was valued at USD 2.9 billion in 2017, emerging as the market leader. Fluoroscopy will register the fastest growth over the forecast period
• While hospitals enjoy the dominant share on the basis of end use, the diagnostic centers segment is anticipated to register a CAGR of 3.6% from 2018 to 2025

Grand View Research has segmented the global x-ray systems market on the basis of modality, mobility, end use, type, and region:

X-ray Systems Modality Outlook (Revenue, USD Million, 2014 - 2025)

• Radiography
• Fluoroscopy
• Computed Radiography

X-ray Systems Mobility Outlook (Revenue, USD Million, 2014 - 2025)

• Stationary
• Mobile

X-ray Systems End Use Outlook (Revenue, USD Million, 2014 - 2025)

• Hospital
• Diagnostic Centers
• Mobile Imaging Centers

X-ray Systems Type Outlook (Revenue, USD Million, 2014 - 2025)

• Digital
• Analog

X-ray Systems Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • Greece
  • Spain
  • Austria
  • Denmark
  • Belgium
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Sri Lanka
  • Bangladesh
  • Singapore
  • South Korea
  • Thailand
  • Malaysia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Kuwait
  • Qatar
  • UAE
  • Saudi Arabia

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

U.S. Emergency Medical Services Products Market is Anticipated To Generate Significant Revenues By 2025

The U.S. emergency medical services (EMS) products market is anticipated to reach USD 15.09 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 7.2% during the forecast period. Burgeoning demand for emergency care, mounting cases of trauma, and growing healthcare spending are the key factors escalating the growth of the market.

Emergency departments manage patients with medical, obstetric, and surgical emergencies. The department is also equipped to treat injuries, infections, heart attacks, asthma, and acute pregnancy complications. The U.S. has hospital-based emergency departments as well as independent emergency departments that operate outside hospital premises. According to the Centers for Disease Control and Prevention (CDC), 141.4 million patients visited emergency rooms in the U.S. in 2014.

Surging demand in the U.S. for emergency medical services creates a favorable environment for market growth. The Centers for Medicare and Medicaid Services (CMS) has divided emergency departments in the U.S. into two segments: Type A and Type B. Type A functions 24 × 7 and Type B includes emergency departments, which operates during a specified period of time. As per Becker's Hospital Review, a magazine for hospital business news, in 2016, the number of emergency department visits in the U.S. was 136.3 million. These figures indicate a strong demand for EMS products.

Moreover, in 1986, the government had introduced the Emergency Medical Treatment and Labor Act (EMTALA). As per the law, anyone going to emergency department has to be treated, regardless of their ability to pay or their insurance status. Such laws are improving the accessibility to emergency care, which in turn can propel the market. 

To request a sample copy or view summary of this report, click the link below:https://www.grandviewresearch.com/industry-analysis/us-emergency-medical-services-ems-products-market

Further Key Findings From the Study Suggest:

• Life support & emergency resuscitation products accounted for the largest share in 2016 owing to their requirement in most of the emergency medical cases.
• Based on end use, Fire department represented the largest share in 2016 as they are usually the first responders and also attend casualties at accident sites.
• Major players of the market include Bound Tree Medical; McKesson Medical-Surgical, Inc.; Henry Schein, Inc.; Medline Industries, Inc.; Stryker Corporation; Smiths Medical; Cardinal Health; and Penn Care Inc.

Grand View Research has segmented the U.S. EMS products market on the basis of product and end-use:

U.S. EMS Products Outlook (Revenue, USD Billion, 2014 - 2025)

• Life support & emergency resuscitation
  • Defibrillators
  • Endotracheal Tubes
  • Ventilators
  • Resuscitators
  • Laryngoscopes
• Patient monitoring systems
• Wound care consumables
  • Dressings & Bandages
  • Sutures & Staples
  • Others
• Patient handling equipment
  • Medical Beds
  • Wheelchairs and scooters
  • Other equipment
• Infection control supplies
  • Disinfectant and Cleaning Agents
  • Personal Protection Equipment
  • Others
• Other EMS products

U.S. EMS Products End-Use Outlook (Revenue, USD Billion, 2014 - 2025)

• Fire Department
• Government/Third Services
• Private transport
• Hospital Owned Services
• Public Utility Services
• Volunteer Services
• Others

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Medical Device Cleaning Market Latest Innovations, Drivers and Industry Key Events by 2025

The global medical device cleaning market size is expected to reach USD 15.9 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 6.3% during the forecast period. High adoption of advanced methods and materials to prevent infections in hospitals and increase in the number of hospitals & other healthcare facilities, including clinics, are expected to boost market growth.

Other key factors expected to enhance the market growth include strict regulations and guidelines to reduce incidences of hospital-acquired infections coupled with introduction of novel methods & materials for cleaning, disinfecting, and sterilizing medical devices. Increase in the number of contractual service providers for reprocessing and manufacturers of materials required in these processes is also anticipated to propel the market.

Guidelines and regulation by U.S. FDA play an important role in determining market dynamics. They profile various materials along with their effects in cleaning & disinfecting medical devices and risks associated with them. In addition, they regulate standards of tests for disinfection. Most developing countries follow similar guidelines, especially those in the Asia Pacific region, where medical tourism is booming and primary customers include patients from developed countries.

To request a sample copy or view summary of this report, click the link below:https://www.grandviewresearch.com/industry-analysis/medical-device-cleaning-market

Further key findings from the report suggest:

• Semi-critical devices accounted for the largest share in 2017 and is expected to dominate throughout forecast period. High usage and need for repeated sterilization between patients are among the key factors anticipated to drive the growth of the segment
• The disinfection segment dominated the market in 2017 and is expected to maintain the largest share throughout the forecast period. Introduction of novel and advanced disinfectants is likely to supplement the growth of the segment
• Sterilization is expected to exhibit the fastest growth during the forecast period. Adoption of advanced sterilization procedures in hospitals is expected to boost the growth of the segment
• Asia Pacific is anticipated to exhibit the highest CAGR during the forecast period. High demand for advanced medical device reprocessing equipment and materials owing to increasing medical tourism is one of the primary growth drivers in the region.

Grand View Research has segmented the global medical device cleaning market on the basis of device type, technique, and region:

Medical Device Cleaning Device Type Outlook (Revenue, USD Million, 2014 - 2025)

• Noncritical
• Semi-critical
• Critical

Medical Device Cleaning Technique Outlook (Revenue, USD Million, 2014 - 2025)

• Cleaning
  • Detergents
  • Buffers
  • Chelators
  • Enzymes
  • Others (Lumen cleaning wires)
• Disinfection
  • Chemical
    • Alcohol
    • Aldehyde
    • Chlorine and Chlorine Compounds
    • Others
  • Metal
  • Ultraviolet
  • Others
• Sterilization
  • Heat Sterilization
  • Ethylene Dioxide
  • Others

Medical Device Cleaning Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • Austria
  • Norway
  • Greece
  • Denmark
  • Spain
  • Belgium
• Asia Pacific
  • China
  • India
  • Japan
  • Bangladesh
  • South Korea
  • Thailand
  • Malaysia
  • Singapore
  • Australia
  • Sri Lanka
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • U.A.E
  • Saudi Arabia
  • Qatar
  • Kuwait

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Vaccine Delivery Devices Market Industry Size, Driving Demands, And Market Share Of Various Stakeholders

The global vaccine delivery devices market size is expected to reach USD 6.21 billion by 2025, according to a new report by Grand View Research, Inc. The market is primarily driven by growing immunization programs, financial support from government & nongovernment organizations, increasing vaccination initiatives & campaigns, and rising prevalence of infectious diseases globally. Growing research in the field of vaccines and development of new products is also contributing to the growth of the market.

Adoption of needle-free approach for administering these products is gaining momentum due to growing awareness and demand to avoid pain & injuries associated with the use of a needle stick. Data by the Centers for Disease Control and Prevention states that an estimated 385,000 sharp injuries including needle stick injuries occur every year in hospitals in the U.S. Advancing technologies in administering vaccines and their increasing adoption is propelling market growth. Rising interest of various key players, national institutions, and organizations in novel delivery technologies is expected to further contribute to market growth.

Various governments and international organizations are increasingly investing in the development of vaccination programs. For instance, the UK government also announced funding up to £1 million from its Global Challenges Research Fund through Medical Research Council to investigate the Zika virus and its transmission. Organizations such as GAVI Alliance, Bill & Melinda Gates Foundation, Path, and WHO are actively involved in the field of vaccines. Many governments are also undertaking several immunization programs on priority.

To request a sample copy or view summary of this report, click the link below:http://www.grandviewresearch.com/industry-analysis/vaccine-delivery-devices-market

Further key findings from the report suggest:

• The syringes segment held majority of the revenue share in 2016 due to increasing vaccination programs, spreading immunization coverage, and technological advancements
• Jet injectors is expected to register highest growth during the forecast period owing to rising concerns regarding needle stick injuries and growing preference for needle-free technologies
• Intramuscular vaccination dominated the route of administration segment in 2016 as majority of vaccines are given through this route owing to its advantages
• North America dominated the global vaccine delivery devices market owing to increasing awareness levels, high adoption of technology, and rising prevalence of infectious diseases
• Some of the key players include Becton Dickinson & Company, Bioject Medical Technologies, Inc. (Inovio Pharmaceutical Inc.); Gerresheimer AG; PharmaJet; Corium International, Inc.; and SCHOTT AG

Grand View Research has segmented the global vaccine delivery devices market on the basis of devices, route of administration, and region:

Vaccine Delivery Devices Outlook (Revenue, USD Million, 2014 - 2025)

• Syringes
• Jet Injectors
• Other Devices

Vaccine Delivery Devices Route of Administration Outlook (Revenue, USD Million, 2014 - 2025)

• Intradermal Vaccination
• Intramuscular vaccination
• Subcutaneous Vaccination
• Other Vaccinations

Vaccine Delivery Devices Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
• Asia Pacific
  • China
  • Japan
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Nebulizer Market is Expected Mark a CAGR of 6.6% Through 2027

The global nebulizer market size is expected to reach USD 1.5 billion by 2027, expanding at a CAGR of 6.6% over the forecast period, according to a new report by Grand View Research, Inc. Rising incidence rate of chronic respiratory diseases, increasing demand for home healthcare devices, and rising geriatric population worldwide are the major factors leading to market growth.

According to the Population Reference Bureau report, "Aging in the United States”, the geriatric population in U.S. is estimated to increase from 48 million in 2016 to 98 million by 2060. Elderly people are susceptible to respiratory diseases such as COPD and sleep apnea. Therefore, growing geriatric population is expected to expand the patient pool for manufacturers and propel the growth of the market.

On the other hand, drug loss during nebulization is the major factor restraining the market. However, this can also act as an opportunity for the mesh nebulizer manufacturers as the devices are manufactured to deliver accurate drug dosage while reduce drug loss. Furthermore, increasing commercial acceptance of mesh nebulizers due to accurate delivery of drug to the lung and lower residual volumes also aids in market growth.

Technological advancements such as drug-device combination is further expected to create new opportunity in the market. The key manufacturers are expected to dominate the market of drug device combinations till the generic mesh nebulizer manufacturers invest in the support infrastructure required for the development of new pharmaceuticals. For instance, in 2016, Sunovion filed the first application for the approval of SUN-101. A mesh nebulizer in combination with a drug for COPD (SUN-101) will be a significant step for boosting the adoption of nebulizers. Other companies such as Vectura also have products in late stage development, e.g., VR475, indicated for severe asthma, in Phase III trials.

Access Research Report of Nebulizer Market@
https://www.grandviewresearch.com/industry-analysis/nebulizers-market

Further key findings from the study suggest:

• The jet segment held over 60.0% market share in 2019 owing to the greater penetration and low cost of the devices
• The mesh segment is expected to be the fastest growing segment with a CAGR of 7.7% over the forecast period, due to various benefits including portability, convenience, homecare application, and accurate dosage delivery
• According to the Population Reference Bureau report, "Aging in the United States”, the geriatric population in U.S. is estimated to increase from 48 million in 2016 to 98 million by 2060
• The demand is expected to increase in homecare application. Easy availability of compact nebulizers that are ideal for home use and technological innovations in the device to reduce the sound created by it and to improve its functionality are increasing its adoption in home healthcare
• North America dominated the nebulizer market in 2019. This high share can be attributed to increase in incidence of respiratory diseases, supportive government policies, favorable reimbursement schemes, rise in awareness, and increasing use of home care products
• As per the analysis of the U.S. and EU clinical trial databases, mesh nebulizers are more preferred for clinical trials sponsored by pharmaceutical companies over jet nebulizers
• Key players include Omron Corporation; Koninklijke Philips N.V.; PARI Pharma; Allied Healthcare Products, Inc.; Becton Dickinson and Company; Agilent Technologies; Medline Industries; Briggs Healthcare; Drive Medical; and GF Health Products, Inc.

Grand View Research has segmented the global nebulizer market on the basis of the type, end use, and region:

Nebulizer Type Outlook (Revenue, USD Million, 2016 - 2027)

• Jet
• Mesh
  • Active
  • Passive
• Ultrasonic

Nebulizer End-Use Outlook (Revenue, USD Million, 2016 - 2027)

• Hospitals and clinics
• Emergency Centers
• Home Healthcare

Nebulizer Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • Singapore
  • Malaysia
  • Indonesia
  • Philippines
• Latin America
  • Mexico
  • Brazil
• MEA
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research    reports, customized research reports, and consulting services. To help clients make informed business    decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Antiseptics and Disinfectants Market Exhibit a Steady 6.7% CAGR through 2026

Antiseptics and Disinfectants Market Size, Share & Trends Analysis Report By Type (Quaternary Ammonium, Chlorine), Product Type (Medical Device Disinfectants), By End Use, And Segment Forecasts, 2019 - 2026

The global antiseptics and disinfectants market size is expected to reach USD 27.99 billion by 2026, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 6.7% during the forecast period. Increasing prevalence of Hospital-acquired Infections (HAIs), awareness about home cleanliness and the need for disinfection, and usage of endoscope reprocesses and surgical units across the globe are the key driving factors.

Rising use of Gastrointestinal (GI) endoscopes and surgical units due to the increasing rate of surgeries across the globe is expected to drive the antiseptics and disinfectants market growth over the forecast period. GI endoscopy is one of the important tools for the treatment and identification of disorders of the gastrointestinal tract. Proper understandings of application to GI endoscopy and infection control is very much essential as it helps to prevent transmission of infection through endoscopes and lapses in reprocessing.

Moreover, endoscopes need to be reprocessed appropriately as per the infection-control guidelines to lower the risk of acquiring environmental or patient-borne microorganisms. Thus, in such cases application of proper antiseptics and disinfectant solutions are very much essential to prevent transmission of infections. In addition, increasing rate of endoscopy is expected to surge the risk of getting such infections.

For instance, as per the BMJ Publishing Group Ltd & British Society of Gastroenterology, published in 2018, the demand for gastrointestinal endoscopy has grown immensely for both and bowel cancer screening and symptomatic patients owing to which overall demand has doubled in many centers in U.K. over the last five years. Such factors are anticipated to drive the growth of antiseptics & disinfectants market.

Access Research Report of Antiseptics and Disinfectants Market @ https://www.grandviewresearch.com/industry-analysis/antiseptics-and-disinfectants-market

Further key findings from the report suggest:

• In terms of revenue, quaternary ammonium compounds segment is expected to hold the largest market share over the forecast period. High prevalence of HAIs is the major factor driving the growth
• Enzymatic cleaners are expected to witness the fastest growth over the forecast period. Increasing rate of surgeries is expected to drive the segment growth as the product is majorly used for disinfection of surgical kits
• Asia-Pacific antiseptics and disinfectants market is expected to witness the fastest growth over the forecast period owing to the increasing number of hospitals and clinics
• Prominent market players are BD, Johnson & Johnson, Novartis AG, and Cardinal Health.

Grand View Research has segmented the global antiseptics and disinfectants market on the basis of type, product type, end use, and region:

Antiseptics and Disinfectants Type Outlook (Revenue, USD Million, 2014 - 2026)

• Quaternary Ammonium Compounds
• Chlorine Compounds
• Alcohols & Aldehyde Products
• Enzyme
• Others

Antiseptics and Disinfectants Product Type Outlook (Revenue, USD Million, 2014 - 2026)

• Enzymatic Cleaners
• Medical Device Disinfectants
• Surface Disinfectants

Antiseptics and Disinfectants End Use Outlook (Revenue, USD Million, 2014 - 2026)

• Hospitals
• Clinics
• Others

Antiseptics and Disinfectants Regional Outlook (Revenue, USD Million, 2014 - 2026)

• North America
• Europe
• Asia-Pacific
• Latin America
• MEA

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Sleep Apnea Devices Market Revenue And Industry Growth At Global, Regional, And Country Level

The global sleep apnea devices market size is projected to reach USD 10.3 billion by 2027, expanding at a CAGR of 7.4% over the forecast period, according to a new report by Grand View Research, Inc. Increasing number of patients suffering from obstructive sleep apnea (OSA) is a key factor expected to drive the market growth. Furthermore, growing awareness about the condition and related comorbidities is likely to drive the growth over the forecast period. However, high cost of diagnosis and treatment for sleeping disorders is one of the key factors anticipated to restrain the market growth.

Based on product type, the market is segmented into diagnostic and therapeutic devices. In 2019, the therapeutic devices segment dominated the market with a revenue share of 64.1%. The penetration of these devices has grown at a lucrative rate over the past few years, owing to promising reimbursement guidelines in various countries. Moreover, availability of technologically advanced and innovative products has enhanced the growth of this segment. On the other hand, the diagnostic device segment is expected to grow at the fastest rate over the forecast period, owing to a rise in the number of patients diagnosed with respiratory disorders.

Based on region, North America dominated the market in 2019 with a revenue share of 51.5%. Presence of major market participants and rising awareness related to sleeping disorders and associated diseases in the region has reinforced the sleep apnea devices industry growth in the region. On the other hand, the Asia Pacific region is expected to grow at the fastest CAGR over the forecast period, owing to rising prevalence of geriatric population suffering from sleep disorders and establishment of sleep laboratory facilities for testing sleep apnea patients.

Access Research Report of Sleep Apnea Devices Market @ https://www.grandviewresearch.com/industry-analysis/sleep-apnea-devices-market

Further key findings from the report suggest:

• The therapeutic devices segment accounted for a major revenue share of 64.1% in 2019 owing to the availability of technologically advanced products
• The diagnostic devices segment is expected to witness a lucrative growth rate of 7.6% owing to increasing number of patients diagnosed with respiratory disorders and rising awareness regarding the disease
• North America dominated the market in 2019, owing to increasing awareness related to obstructive sleep apnea (OSA) and associated comorbidities in the region
• Some of the key players in the sleep apnea devicesmarket are Curative Medical Inc.; Philips Respironics; ResMed; Fisher & Paykel Healthcare; Cadwell Laboratories; and Invacare Corporation.

Grand View Research has segmented the global sleep apnea devices market based on product type and region:

Sleep Apnea Devices Product Type Outlook (Revenue, USD Million, 2016 - 2027)

• Therapeutic Devices
  • Positive Airway Pressure (PAP)
  • Oral
  • Nasal
  • Chin Straps
• Diagnostic Devices
  • Actigraphs
  • Polysomnography (PSG)
  • Respiratory Polygraphs
  • Pulse Oximeters

Sleep Apnea Devices Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • Spain
  • France
  • Italy
  • Russia
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Australia
• Latin America
  • Mexico
  • Brazil
  • Argentina
• MEA
  • South Africa
  • Egypt
  • Tunisia

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Active Pharmaceutical Ingredient Market is Expected to Amplify USD 268.6 Billion Value by 2027

The global active pharmaceutical ingredient market size is expected to reach a value of USD 286.6 billion by 2027, according to a new report by Grand View Research, Inc., registering a CAGR of 6.7% over the forecast period. Factors, such as increasing preference for outsourcing APIs and growing prevalence of various target diseases such as cancer and Cardiovascular Diseases (CVDs) are expected to drive the market growth.

A steady rise in consumer demand for APIs, especially in developing and under-developed countries, increases the adoption of these products. In addition, strategic collaborations play a key role in the adoption of these ingredients in various regions. For instance, in February 2019, Cipla Inc. partnered with Wellthy Therapeutics Private Limited to combine digital therapeutics and pharmacotherapy for better patient outcomes in cardiovascular diseases and diabetes.

Private and public initiatives to manufacture active pharmaceutical ingredients within their countries, especially in developing countries such as India, is expected to drive the growth of the market. For instance, API production in India is promoted under the “Make in India” initiative.

Presence of prominent players and increasing government initiatives for the development of pharmaceuticals in various regions are also expected to boost the market growth. Increasing consumer awareness and demand for economical and effective treatment strategies, especially in Asia Pacific and Middle East and Africa, are driving the sales channels. In addition, high adoption and growing usage of online pharmacies are likely to drive the e-commerce sales of APIs.

The API market is competitive in nature and is becoming increasingly competitive. Consequently, manufacturers are required to enhance products in order to gain advantage over previously marketed products. For instance, in March 2019, Dr. Reddy’s Laboratories Ltd. launched XCEED-a B2B customer service portal. The platform was designed to manage the growing demand for generic active pharmaceutical ingredients by significantly increasing operational efficiency.

Access Research Report of Active Pharmaceutical Ingredient Market @ https://www.grandviewresearch.com/industry-analysis/active-pharmaceutical-ingredients-market

Further key findings from the study suggest:

• On the basis of type of synthesis, the synthetic segment dominated the active pharmaceutical ingredients market in 2019 owing to easy availability of raw materials and easier protocols in place for the synthesis of these molecules
• The biotech segment is estimated to register the highest CAGR owing to higher efficiency of these molecules and increasing demand for biopharmaceuticals
• Captive manufacturers held the largest share in 2019 due to easy availability of raw materials
• The merchant manufacturers segment is estimated to witness a lucrative CAGR over the forecast period
• The generic segment is estimated to register the highest CAGR over the forecast period. The segment is driven by factors such as lower cost and expiration of patents of branded drugs
• Asia Pacific is estimated to register a significant CAGR of 8.0% owing to the increasing number of pharmaceutical manufacturing plants in the region
• Some of the key players in the API market are Mylan N.V.; Teva Pharmaceutical Industries Ltd.; Boehringer Ingelheim International GmbH; AbbVie Inc.; Merck & Co., Inc.; Cipla Inc.; Albemarle Corporation; Dr. Reddy’s Laboratories Ltd.; Bristol-Myers Squibb Company; Aurobindo Pharma; and Sun Pharmaceutical Industries Ltd.

Grand View Research has segmented the global active pharmaceutical ingredients market on the basis of type of synthesis, type of manufacturer, type, application, and region:

API Type of Synthesis Outlook (Revenue, USD Billion, 2015 - 2027)

• Biotech
  • Monoclonal antibodies
  • Recombinant proteins
  • Vaccines
• Synthetic

API Type of Manufacturer Outlook (Revenue, USD Billion, 2015 - 2027)

• Captive APIs
• Merchant APIs

API Type Outlook (Revenue, USD Billion, 2015 - 2027)

• Generic APIs
• Innovative APIs

API Application Outlook (Revenue, USD Billion, 2015 - 2027)

• Cardiology
  • Generic
  • Innovative
• Oncology
  • Generic
  • Innovative
• CNS & Neurology
  • Generic
  • Innovative
• Orthopedic
  • Generic
  • Innovative
• Endocrinology
  • Generic
  • Innovative
• Pulmonology
  • Generic
  • Innovative
• Gastroenterology
  • Generic
  • Innovative
• Nephrology
  • Generic
  • Innovative
• Ophthalmology
  • Generic
  • Innovative
• Others

API Regional Outlook (Revenue, USD Billion, 2015 - 2027)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Mexico
  • Brazil
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Global Biologics Market Register Healthy CAGR of 3.9% from 2017 to 2025: Grand View Research Inc.

The global biologics market is anticipated to reach USD 399.5 billion by 2025, according to a new report by Grand View Research, Inc. Introduction of targeted therapies coupled with rising adoption of patient centric personalized medicine anticipated to fuel demand. Ever-increasing understanding of the cell physiology and stress, as well as the factors involved in protein production and heterologous gene expression have empowered the use of different living factories.

Multiple therapeutic regimens are being followed across the globe in attempts to come up with a reliable treatment for Covid-19. One line of treatment includes the use of hydroxychloroquine, while a second treatment line focuses to use antiviral drugs used in the disease management of HIV. Both these approaches have surged demand from advanced antivirals and antimalarial drugs. This impacts the drug manufacturers as an off label indication for these drug classes has to be worked upon. At the moment, the WHO has not prescribed any of these approaches, neither they have commented if one is better than the other. The report will account for Covid19 as a key market contributor.

These living factories are the prokaryotic and eukaryotic cells. Enhancement of drug functionality through achieving successful protein folding and post-translational modifications is supportive for projected progress rate.

Moreover, rising adoption of biopharmaceuticals over chemically synthesized molecules is expected to propel revenue generation significantly. In addition to this, presence of several metabolic disorders that can be treated through the use of biologics is attributive to influence demand.

Combination of advanced bioengineering technologies for biopharmaceutical production is expected to boost progress in pharmaceutical industry. With recent advances in automation, the selection process can be done through high throughput screening (HTS) system for selection of viable clones.

Aforementioned method enables robust production of biopharmaceutical products by obtaining high-producing cell line. Advances with respect to upstream and downstream processing would directly translate into the growth in revenue for this market at a larger level.

However, development of biosimilars is expected to restrain the biologics year on year growth to certain extent. Although, the regulatory approval pathway for these products is not framed yet some drug manufacturers are opting to invest in the development of biobetters.

Access Research Report of Biologics Market @ http://www.grandviewresearch.com/industry-analysis/biologics-market

Further key findings from the report suggest:

• Microbial expression systems dominated the market with respect to biopharmaceutical manufacturing
• Presence of substantial number of products manufactured through the use of microbial sources can be attributed for largest share
• Higher usage of monoclonal antibodies for the treatment of different diseases responsible for revenue generation
• Moreover, pipeline drugs in the phase of development anticipated to bolster growth
• Significant development pertaining to vaccines and increasing adoption anticipated to fuel progress
• Oncology dominated over a decade and is expected to sustain its share over the forecast period.
• Introduction of novel biologics with high efficacy coupled with the augmenting incidences of cancer is the vital impact rendering factor.
• Substantial sales of biologics in the U.S. can be attributed for the largest share of North American market.
• Established participants are implementing the manufacture of complex moieties in-house, which pronounces for the larger share of in-house manufacturing.
• Asia Pacific is projected to showcase fastest growth in the coming years.
• Increasing penetration of the biologics in the developing economies is expected to contribute in the projected growth.
• Moreover, the university based projects implemented herein are attributive for the projected growth.
• Key players contributing in this market are F Hoffman La Roche, Samsung Biologics, Celltrion, Pfizer Inc., Amgen, Novo Nordisk A/S, Sanofi, Abbvie Inc., Merck & Co. Inc, Addgene, Johnson & Johnson Services Inc., and Eli Lilly & Company.
• These participants are investing in the hybrid business models through providing technology and service platforms.
• Such milestones and royalties from partnered programs enables the cash flow generation which can be utilized in proprietary R&D.

Grand View Research has segmented the biologics market on the basis of source, product, manufacturing, disease category, and region:

Biologics Source Outlook (Revenue, USD Billion, 2014 - 2025)

• Microbial
• Mammalian
• Others

Biologics Product Outlook (Revenue, USD Billion, 2014 - 2025)

• Monoclonal Antibodies

Biologics Manufacturing Outlook (Revenue, USD Billion, 2014 - 2025)

• In-house
• Outsourced

Biologics Disease Category Outlook (Revenue, USD Billion, 2014 - 2025)

• Oncology
• Infectious Diseases
• Immunological Disorders
• Cardiovascular Disorders
• Hematological Disorders
• Others

Biologics Regional Outlook (Revenue, USD Billion, 2014 - 2025)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa (MEA)

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Medical specialty bags market is Anticipated to Register 4.8% CAGR through 2020| Top Industry Players Terumo Corporation

The medical specialty bags market is expected to reach USD 10.31 billion by 2020 with the advent of technology and increasing demand that emphasizes on customer value proposition of products and services.Growing percentage of aging population and prevailing diseases such as urinary incontinence is expected to be the key driving factor for marketgrowth over the next seven years. 

With the recent global pandemic of SARS COV2, citizens worldwide have been requested to remain within houses to prevent further spread of infection. As hospitals are overburdened with newer patients and the number of available patient beds decline, many non-critical patients are sent back home to recover. However, often such patients require immediate medical attention as symptoms worsen. Paramedics are therefore required to show up at patient houses and administer immediate treatment. As houses are remote settings with limited medical resources, paramedics carry specialty bags that enable them to tote essential medical supplies when needed. The demand for medical specialty bags is therefore expected to see an upsurge owing to the increased frequency of house visits by paramedics in covid-19 affected regions. We are working to account for this surge in our estimates. The updated report will account for Covid-19 as a key market contributor.

Government policies and initiatives intended to draw customer attention by improving cost effectiveness of product offering is expected to drive demand over the forecast period. Streamlined reimbursement policies to make the product more attractive is also expected to play a major role in the growth of medical speciality bag market over the forecast period. 

Rise in the disposable income and growing health awareness regarding various diseases coupled with increasing unmet medical needs and introduction of affordable medical specialty bags in emerging economies such as Brazil, China and India is anticipated to propel future growth of the industry. High excise tax rates on healthcare devices in theU.S and Canada is expected to serve as key challenge for medical specialty bags market over the next seven years. 

Based on the type of product, medical specialty bag market is broadly classified into urinary collection bags, anesthesia breathing bags, sterile packaging bags, blood bags, bile collection bags, cadaver bags, ostomy bags, enteral feeding bags, intravenous fluid bags and continuous ambulatory peritoneal dialysis bags. (CAPD). 

Access Research Report of Medical specialty bags market @ www.grandviewresearch.com/industry-analysis/medical-specialty-bags-market

Ostomy collection bags was the largest product segment in 2013 and is estimated to grow at a CAGR of 4.3% from 2014 to 2020 to reach USD 2.94 billion. Bile collection bags, on the other hand, are expected to grow at a fast pace with a CAGR of 6.5% from 2014 to 2020, on account of rising need for minimally invasive laparoscopic cholecystectomy procedures. 

Intravenous (IV) fluid bags market revenue is estimated to reach USD 2,469.9 million by 2020, growing at a CAGR of 5.2% from 2014 to 2020. Medical specialty bags comprise niche segments including home healthcare and SurgiCenters. Small non-hospital players such as SurgiCenters are expected to drive the market growth owing to increasing demand and customer awareness. These bags are used for surgeries in hospitals. 

North America accounted for the largest share of the market in 2013 owing to the existence of sophisticated healthcare infrastructure, better patient awareness levels and reimbursement framework.These elements are responsible for high rates of usage and procedure volumes in the region. 

Asia Pacific medical specialty bags markets expected to grow at the highest CAGR of over 6.0% from 2014 to 2020. Improved medical knowledge, in addition to improving healthcare infrastructure and disbursements are some of the factors expected to account for its rapid growth over the forecast period. 

Key participants of this market include Fresenius Medical Care AG & Co, Hollister Incorporated, Terumo Corporation, Baxter International Inc., B Braun Medical Convatec Inc. and Coloplast A/S.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.